News | July 28, 2010

Medicare Radiopharmaceutical Coding, Payment Policy Corrected

July 28, 2010 – The Council on Radionuclides and Radiopharmaceuticals (CORAR) applauded a recent decision by a Medicare administrative to correct coding, coverage and payment policies for radiopharmaceuticals used with myocardial perfusion imaging procedures.

The contractor, Trailblazer Health Enterprises LLC, updated language regarding billing for technetium diagnostic radiopharmaceuticals (A9500) and (A9502) used in multiple myocardial perfusion imaging studies (CPT 78452), which incorrectly limited payment to one dose.

“For the past several years, CORAR members and the Society of Nuclear Medicine (SNM), the American College of Radiology (ACR), the American College of Cardiology (ACC), and the American Society of Nuclear Cardiology (ASNC) have requested that Trailblazer adjust its policy so that providers may bill and be appropriately reimbursed when two technetium heart agent radiopharmaceutical doses are administered consistent with appropriate clinical practice guidelines,” said Michael Guastella, current chairman of the CORAR Healthcare Policy Committee for Reimbursement.

Guastella said the policy in question was inconsistent with good clinical practice and hospital and pharmacy standards. CORAR worked with the medical specialty societies to bring this issue to the attention of CMS. In a letter dated May 21, CORAR brought this issue to the attention of the deputy regional administrator for the Dallas Regional Office of the Centers for Medicare and Medicaid Services (CMS). In response, CMS’s Division of Financial Management and Fee for Service Operations, Region VI consulted with clinical and policy staff at the CMS Central Office and contacted Trailblazer’s medical director. In response to CORAR’s letter the CMS Regional Office communicated that Trailblazer would be withdrawing the language regarding billing for more than one unit of technetium heart agent radiopharmaceutical (A9500) and (A9502) and no longer limit billing to a single dose.

“We believe that this change will allow providers to bill appropriately for the diagnostic radiopharmaceuticals administered while being consistent with Medicare HCPCS coding guidelines, clinical standards and product labeling standards.” said Gail Daubert of ReedSmith, legal counsel to CORAR.

CORAR is an industry trade association comprised of North American manufacturers, developers and suppliers of radiopharmaceuticals and radionuclides primarily used in nuclear medicine and life science research.

Related Content

New PET-CT Scan Improves Detection in Rare Cardiac Condition
News | PET-CT| July 25, 2017
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests,...
Sponsored Content | Videos | Business| July 13, 2017
Randall Thompson, M.D., outlines three new CPT codes for FFR-CT, a smart phone-based single-lead ECG system and PET n
Novel PET Tracer Detects Small Blood Clots

PET images (MIP 0-60 min) of three Cynomolgus monkeys. Strong signals are detected at the sites where inserted catheters had roughened surfaces. Almost no other background signal is visible. Only accumulation in the gallbladder becomes visible at the bottom of the image. Credit: Piramal Imaging GmbH, Berlin Germany.

News | PET Imaging| July 07, 2017
Blood clots in veins and arteries can lead to heart attack, stroke and pulmonary embolism, which are major causes of...
Sponsored Content | Videos | Clinical Decision Support| June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
cardiac nuclear myocardial perfusion imaging (MIP) exam guidelines for women
News | Nuclear Imaging| June 15, 2017
June 15, 2017 — The American Society of Nuclear Cardiology (ASNC) has published an updated consensus statement on evi
Philips Dosewise portal allows X-ray radiation dose tracking for individual patients

An example of radiation dose tracking software is Philips Dosewise portal, which allows X-ray radiation dose tracking for individual patients by modality, body region and exam type.

Feature | Radiation Dose Management| June 13, 2017 | Dominic Siewko
In recent years, radiation dose management awareness has heightened across the healthcare industry to address growing
MIM Software Inc. Announces Updates to MIM Encore
Technology | Remote Viewing Systems| May 31, 2017
MIM Software Inc. recently announced significant updates to its MIM Encore solution for viewing nuclear medicine images...
News | Enterprise Imaging| May 25, 2017
At the 2017 annual meeting of the Society for Imaging Informatics in Medicine (SIIM), June 1-3 in Pittsburgh, Konica...
Lantheus and GE Healthcare Sign Agreement for Worldwide Development, Commercialization of Flurpiridaz F-18
News | Radiopharmaceuticals and Tracers| May 22, 2017
Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced the signing of a...
Overlay Init